GlassScriptPhysician profile
Kathryn Ortmann
NPI 1750913927
$1,069.55
in general payments reported to CMS, 2019-2025
13 companies · $953 in 2025
The $953 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8.56 · 2023: $18.00 · 2024: $90.08 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.00 |
| Education | $260.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $391.43 | 2024-2025 | Tremfya |
| Genzyme Corporation | $156.45 | 2025 | |
| Galderma Laboratories, L.P. | $155.22 | 2025 | Nemluvio |
| Abbvie INC. | $91.04 | 2025 | |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Ucb, INC. | $38.25 | 2025 | Bimzelx |
| Genentech USA, INC. | $29.28 | 2025 | Xolair |
| Leo Pharma INC. | $26.30 | 2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $24.15 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.80 | 2025 | Sotyktu |
| Amgen INC. | $18.08 | 2024 | Otezla |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.00 | 2023 | Lifevest |
| Sunovion Pharmaceuticals INC. | $8.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ortmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.